Systemic therapy of liver cancer-Reference-Cited by-同舟云学术

Systemic therapy of liver cancer

Published:2021 Issue: Volume: Page:257-294
ISSN:0065-230X
Container-title:Advances in Cancer Research
language:
Short-container-title:

Author:

Demir Tarik,Lee Sunyoung S.,Kaseb Ahmed O.

Publisher

Elsevier

Reference112 articles.

1. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma;Abou-Alfa;The New England Journal of Medicine,2018

2. Assessment of treatment with sorafenib plus doxorubicin vs sorafenib alone in patients with advanced hepatocellular carcinoma: Phase 3 CALGB 80802 randomized clinical trial;Abou-Alfa;JAMA Oncology,2019

3. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: Data from the fibrolamellar carcinoma consortium;Ang;Gastrointestinal Cancer Research,2013

4. Progression after immunotherapy for fibrolamellar carcinoma;Bauer;Visceral Medicine,2019

5. Interferon-alpha up-regulates the expression of PD-L1 molecules on immune cells through STAT3 and p 38 signaling;Bazhin;Frontiers in Immunology,2018

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1;Journal of Biological Chemistry;2024-02

2. Arenobufagin regulates the p62-Keap1-Nrf2 pathway to induce autophagy-dependent ferroptosis in HepG2 cells;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-02

3. hsa_circ_0002980 prevents proliferation, migration, invasion, and epithelial-mesenchymal transition of liver cancer cells through microRNA-1303/cell adhesion molecule 2 axis;Aging;2023-12-19

4. Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma;BMC Cancer;2023-10-18

5. The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma;Cancers;2023-10-07